【ハイブリッド開催】日英ライフサイエンスセミナー / UK-Japan Life Science Seminar 　英国ライフサイエンスイノベーションエコシステム最新潮流　～日英コラボレーションが加速～

※由良氏、松永氏、曽山はリアル会場での参加、英国からの登壇者は英国現地からのライブ参加を予定しております。一部登壇者がオンライン参加となりますことをあらかじめご了承ください。
※若干の延長の可能性がございます。

登壇者

由良 毅　（駐日英国大使館、アジア太平洋地域ライフサイエンス部門長）
Takeshi graduated in chemistry from the University of Tokyo and earned his PhD at the same institute, studying asymmetric synthetic reactions. Starting out as a medicinal chemist, Takeshi held roles of increasing responsibility in the pharmaceutical industry, including management of drug discovery units and research site head. Takeshi has worked for 10 years in Singapore and India, leading CRO (contract research organization) research sites. He has been the regional head for healthcare and life sciences at the British Embassy in Japan since 2021.

Hamish Ryder　(Chief Executive Officer, Therapeutic Innovation, Cancer Research Horizons)
Prior to appointment as CEO of our new Therapeutic Innovation organisation Hamish directed CRUK’s Therapeutic Discovery Labs for 14 years. He led the transition of the translational strategy to a themed multi-project alliance model where industry partners and academic researchers are brought together from the earliest stages of target selection and validation. Prior to joining CRUK he held positions in biopharma companies for over 20 years, most recently as Director of Research at Almirall, Spain’s largest pharmaceutical company. He has worked across multiple therapeutic areas, leading organisations that have discovered >30 candidate drugs for regulatory development, that have so far yielded 2 marketed therapies. Hamish obtained a degree in Natural Sciences and a PhD in organic chemistry from the University of Cambridge.

Ivana Poparic　(Head of Life Sciences Cluster Development, MedCity）
Ivana Poparic is MedCity’s Head of Cluster Development, leading cluster development with focus on life sciences infrastructure and real estate development as well as international relationships to attract more inward investment and research collaborations to London and beyond.Ivana has extensive scientific and commercial expertise and leadership across the innovation pathway for drugs, devices and digital technologies. Following PhD in Molecular Medicine her experience includes academic research, technology transfer, clinical research, investment, and business development.

パネリスト
曽山 明彦　（一般社団法人ライフサイエンス・イノベーション・ネットワーク・ジャパン常務理事、東北大学客員特任教授、厚生労働省医療系ベンチャー振興推進会議構成員）

モデレーター
松永 昌之　 (Senior Consultant, Oxentia 、LINK-Jサポーター)
25+ year early stage business development support between the UK and Japan. Microbiologist, market and business development specialist.